论文信息 - Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy. - 字舞流文

Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy.

A. Haese* | T. Schlomm | H. Heinzer | B. Beyer | M. Graefen | U. Michl | G. Salomon | T. Steuber | L. Budäus | H. Huland | P. Tennstedt | S. Ahyai | D. Tilki | S. Oh | Frederike Molfenter | Imke Thederan